Search
for
Sort by
Research 61–90 of 1000+
- Replicative stress, stem cells and aging
- Olympic and Board Game Dermatology: Exploring Eponyms Linking Skin Conditions to Sports and Strategy Games
- The P&P Hairline Laser: A Novel Hands-Free Laser-Assisted Hairline Device for Hair Restoration Surgery
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Management of congenital ichthyoses: European guidelines of care, part two
- The role of lymphocytes in the development and treatment of alopecia areata
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Approach to Hair Loss in Women of Color
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Wnt is back in drugmakers' sights, but is it druggable?
- Revisión sistemática de los efectos adversos cutáneos causados por fármacos inhibidores de los puntos de control inmunitario: características, manejo y pronóstico
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia
- Association between serum melatonin and skin aging in an urban population of Mongolia
- Evaluation of polyamide synthetic hair. A long-term clinical study.
- Biofibre hair implant: what is new, what is true?
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Sintilimab-induced Alopecia Universalis in a Patient With the Anti-tumor Effect of Complete Remission After Hepatectomy
- Cutaneous lupus erythematosus induced by tislelizumab
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
- Comprehensive Genomic Profiling of Cutaneous Adnexal Carcinomas: A Genomic Landscape Study
- Immunotherapy-Induced Scarring Alopecia: A Case Series
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Supplementary Material for: Immunotherapy-Induced Scarring Alopecia: A Case Series
- Association of prior 5-α-reductase inhibitor exposure with ICI benefit in metastatic RCC: Multicentre cohort with single-cell immune profiling.
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology